Use of CLL1 and CD45RA As Biomarkers for Leukemia Stem Cells in Acute Myeloid Leukemia Re-Induction Therapy Decision Making

被引：0
|
作者：
Lin, Hong [1 ]
Lee, Christina [2 ]
Tufano, Danielle Marie [3 ]
Liu, Suhu [4 ]
机构：
[1] Stony Brook Univ Hosp, Dept Pathol, Stony Brook, NY USA
[2] Weill Cornell Med, New York, NY USA
[3] Stony Brook Univ Hosp, Stony Brook, NY USA
[4] Stony Brook Univ Hosp, Dept Med, Stony Brook, NY USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-182546
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] CD45dimCD34+CD38-CD133+ cells have the potential as leukemic stem cells in acute myeloid leukemia
    Heo, Sook-Kyoung
    Noh, Eui-Kyu
    Ju, Lan Jeong
    Sung, Jun Young
    Jeong, Yoo Kyung
    Cheon, Jaekyung
    Koh, Su Jin
    Min, Young Joo
    Choi, Yunsuk
    Jo, Jae-Cheol
    BMC CANCER, 2020, 20 (01)
  • [22] Isotype conversion of CD45RA to CD45RO as an early event in ARA-C induced apoptosis of acute lymphoblastic leukemia (ALL) cells.
    Jiang, S
    Konopleva, M
    Bseiso, A
    Zhao, S
    Andreeff, M
    BLOOD, 1996, 88 (10) : 256 - 256
  • [23] Modified EASIX scores predict severe CRS/ICANS in patients with acute myeloid leukemia following CLL1 CAR-T cell therapy
    Yifan Zhao
    Xiaomei Zhang
    Meng Zhang
    Ruiting Guo
    Yi Zhang
    Yedi Pu
    Haibo Zhu
    Pengjiang Liu
    Yu Zhang
    Xiaoyuan He
    Cuicui Lyu
    Hairong Lyu
    Xia Xiao
    Mingfeng Zhao
    Annals of Hematology, 2024, 103 : 969 - 980
  • [24] Modified EASIX scores predict severe CRS/ICANS in patients with acute myeloid leukemia following CLL1 CAR-T cell therapy
    Zhao, Yifan
    Zhang, Xiaomei
    Zhang, Meng
    Guo, Ruiting
    Zhang, Yi
    Pu, Yedi
    Zhu, Haibo
    Liu, Pengjiang
    Zhang, Yu
    He, Xiaoyuan
    Lyu, Cuicui
    Lyu, Hairong
    Xiao, Xia
    Zhao, Mingfeng
    ANNALS OF HEMATOLOGY, 2024, 103 (03) : 969 - 980
  • [25] CD45dimCD34+CD38−CD133+ cells have the potential as leukemic stem cells in acute myeloid leukemia
    Sook-Kyoung Heo
    Eui-Kyu Noh
    Lan Jeong Ju
    Jun Young Sung
    Yoo Kyung Jeong
    Jaekyung Cheon
    Su Jin Koh
    Young Joo Min
    Yunsuk Choi
    Jae-Cheol Jo
    BMC Cancer, 20
  • [26] Dual CD33/CLL-1 Targeted CAR T Cells for Treatment of Acute Myeloid Leukemia
    Kowal, Kevin
    Kim, Miriam
    Ritchey, Julie
    Cooper, Matthew
    O'Neal, Julie
    Di Persio, John
    MOLECULAR THERAPY, 2022, 30 (04) : 401 - 401
  • [27] Case report: Successful combination of CLL1 CAR-T therapy and hematopoietic stem cell transplantation in a 73-year-old patient diagnosed with refractory acute myeloid leukemia
    Zhao, Yifan
    Wang, Hao
    Zhang, Yu
    Zhang, Yi
    Zhang, Xiaomei
    Zhao, Mohan
    Liu, Jile
    Guo, Shujing
    Zhao, Mingfeng
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [28] A phase 1 study of the antibody-drug conjugate brentuximab vedotin with re-induction chemotherapy in patients with CD30-expressing relapsed/refractory acute myeloid leukemia
    Narayan, Rupa
    Blonquist, Traci M.
    Emadi, Ashkan
    Hasserjian, Robert P.
    Burke, Meghan
    Lescinskas, Christopher
    Neuberg, Donna S.
    Brunner, Andrew M.
    Hobbs, Gabriela
    Hock, Hanno
    McAfee, Steven L.
    Chen, Yi-Bin
    Attar, Eyal
    Graubert, Timothy A.
    Bertoli, Christina
    Moran, Jenna A.
    Bergeron, Meghan K.
    Foster, Julia E.
    Ramos, Aura Y.
    Som, Tina T.
    Vartanian, Megan K.
    Story, Jennifer L.
    McGregor, Kristin
    Macrae, Molly
    Behnan, Tanya
    Wey, Margaret C.
    Rae, Jessica
    Preffer, Frederic, I
    Lesho, Patricia
    Duong, Vu H.
    Mann, Mason L.
    Ballen, Karen K.
    Connolly, Christine
    Amrein, Philip C.
    Fathi, Amir T.
    CANCER, 2020, 126 (06) : 1264 - 1273
  • [29] Intracellular retention of TCRαβ/CD3 to generate novel allogeneic CAR-T cells targeting CLL1 for treating acute myelocytic leukemia
    Li, Jun
    Liu, Kaichun
    Xu, Guanggui
    Chen, Shanshan
    Zhang, Yinhang
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [30] Outcomes of Patients Treated with Low-Intensity Re-Induction Therapy for Persistent Disease after a Single Intensive Induction Cycle for Newly Diagnosed Acute Myeloid Leukemia (AML)
    Abedin, Sameem
    Taylor, Skyler
    Murthy, Guru Subramanian Guru
    Runaas, Lyndsey
    Michaelis, Laura C.
    Carlson, Karen-Sue
    Atallah, Ehab L.
    BLOOD, 2022, 140 : 11020 - 11021
12345